Sientra Inc.

0.17
-0.04 (-20.56%)
At close: Feb 21, 2024, 9:00 PM

Company Description

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally.

It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.

The company also provides body contouring products; facial and nasal implants; saline filled sizers.

It serves to hospitals, surgery centers, plastic surgeons, dermatologists and other specialties.

The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007.

Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.

Sientra Inc.
Sientra Inc. logo
Country United States
IPO Date Oct 29, 2014
Industry Medical - Devices
Sector Healthcare
Employees 304
CEO Ronald Menezes

Contact Details

Address:
420 South Fairview Avenue
Santa Barbara, California
United States
Website https://sientra.com

Stock Details

Ticker Symbol SIEN
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001551693
CUSIP Number 82621J105
ISIN Number US82621J1051
Employer ID 20-5551000
SIC Code 3842

Key Executives

Name Position
Ronald Menezes President, Chief Executive Officer & Director
Andrew C. Schmidt Senior Vice President, Treasurer & Chief Financial Officer
Matt Hostetler Chief People Officer
Adelle Walker Senior Vice President of Corporate Strategy & Marketing
Caroline F. Van Hove Executive Chair of Board of Directors
Dr. Denise Dajles Chief Technical Officer
Keith J. Sullivan Director & Advisor to MiraDry Business
Mark S. Saxton Senior Vice President Sales
Oliver Christian Bennett Senior Vice President, Chief Legal, Compliance, & Corporate Development Officer

Latest SEC Filings

Date Type Title
Jun 25, 2024 15-12G Filing
Jun 25, 2024 8-K Current Report
Apr 29, 2024 8-K Current Report
Apr 18, 2024 8-K Current Report
Apr 09, 2024 25-NSE Filing
Mar 29, 2024 NT 10-K Filing
Feb 20, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Feb 16, 2024 8-K Current Report
Feb 13, 2024 8-K Current Report
Feb 06, 2024 SC 13G Statement of acquisition of beneficial ownership b...